検索
Drugs Made In America Acquisition II Ord Shs
DMIIウォッチリストに追加
10.010USD
-0.010-0.10%
終値 05/08, 16:00（ET）15分遅れの株価
637.64M時価総額
31.77直近12ヶ月PER
詳細情報 Drugs Made In America Acquisition II Ord Shs 企業名
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Ord Shsの企業情報
企業コードDMII
会社名Drugs Made In America Acquisition II Corp
上場日Sep 25, 2025
最高経営責任者「CEO」Stockwell (Lynn)
従業員数- -
証券種類Ordinary Share
決算期末- -
本社所在地1 East Broward Boulevard
都市FT LAUDERDALE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号33301
電話番号19548703099
ウェブサイト
企業コードDMII
上場日Sep 25, 2025
最高経営責任者「CEO」Stockwell (Lynn)
Drugs Made In America Acquisition II Ord Shsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Thu, Feb 19
更新時刻: Thu, Feb 19
株主統計
種類
株主統計
株主統計
比率
Drugs Made In America Acquisition II LLC
4.64%
Magnetar Capital Partners LP
4.24%
Glazer Capital, LLC
3.69%
First Trust Capital Management L.P.
3.25%
Conaway (Charles C.)
3.14%
他の
81.04%
株主統計
株主統計
比率
Drugs Made In America Acquisition II LLC
4.64%
Magnetar Capital Partners LP
4.24%
Glazer Capital, LLC
3.69%
First Trust Capital Management L.P.
3.25%
Conaway (Charles C.)
3.14%
他の
81.04%
種類
株主統計
比率
Hedge Fund
29.83%
Investment Advisor/Hedge Fund
16.78%
Investment Advisor
8.57%
Individual Investor
8.48%
Corporation
6.74%
Pension Fund
2.12%
Research Firm
1.24%
Bank and Trust
0.20%
他の
26.04%
機関投資家保有株
更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
1
666.67K
0.00%
--
2026Q1
58
37.42M
58.75%
+33.66M
2025Q4
7
3.04M
4.64%
+3.04M
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Drugs Made In America Acquisition II LLC
4.83M
7.37%
+4.83M
--
Dec 03, 2025
Magnetar Capital Partners LP
2.70M
4.12%
+2.70M
--
Dec 31, 2025
Glazer Capital, LLC
2.35M
3.58%
+2.35M
--
Dec 31, 2025
First Trust Capital Management L.P.
2.07M
3.15%
+2.07M
--
Dec 31, 2025
Conaway (Charles C.)
2.00M
3.05%
+2.00M
--
Dec 03, 2025
Hudson Bay Capital Management LP
1.97M
3%
+1.97M
--
Dec 31, 2025
Wolverine Asset Management, LLC
1.06M
1.62%
+1.06M
--
Dec 31, 2025
Tenor Capital Management Co., L.P.
1.50M
2.29%
+1.50M
--
Dec 31, 2025
Polar Asset Management Partners Inc.
1.50M
2.29%
+1.50M
--
Dec 31, 2025
Millennium Management LLC
1.50M
2.29%
+1.50M
--
Dec 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
